9
Fibromyalgia and Sleep

https://doi.org/10.1016/j.berh.2011.03.004Get rights and content

Chronic pain in fibromyalgia patients, together with its associated symptoms and co-morbidities, is now considered a result of dysregulated mechanisms in the central nervous system (CNS).

As fibromyalgia patients often report sleep problems, the physiological processes that normally regulate sleep may be disturbed and overlap with other CNS dysfunctions. Although the mechanisms potentially linking chronic widespread pain, sleep alterations and mood disorders have not yet been proven, polysomnography findings in patients with fibromyalgia and non-restorative sleep and their relationships with clinical symptoms support the hypothesis of a conceptual common mechanism called ‘central sensitisation’.

Food and Drug Administration (FDA)-approved drugs for the treatment of fibromyalgia may benefit sleep, but their label does not include the treatment of fibromyalgia-associated sleep disorders. Non-pharmacological therapies (including a thorough sleep assessment) can be considered in the first-line treatment of non-restorative sleep, although they have not yet been fully investigated in patients with fibromyalgia. Both pharmacological and non-pharmacological treatments should be used cautiously in patients with fibromyalgia, bearing in mind the patients’ underlying disorders and the potential interactions of the therapies.

Section snippets

Definitions

The exact mechanisms of the relationship between sleep and health are still a subject of research, but it is generally agreed that sleep is regulated by a complex network of physiological processes and substantially contributes to multiple physiological functions, including cardiovascular, endocrine, immunological, psychiatric and neurological functions [12], *[13], *[14], *[15]. Consequently, poor sleep quality or quantity increases the risk of medical and psychiatric diseases [16], [17], [18].

Epidemiology and clinical features

FM patients often report sleep disturbances, including NRS, insomnia, early morning awakening and poor quality sleep [31], [32]. Roizenblatt et al. [32] found that FM patients experience significantly poorer sleep quality than controls, and reported worsening pain symptoms after poor sleep. An Internet survey of more than 2500 FM patients in the USA listed morning stiffness, fatigue, NRS, pain and concentration and memory problems as the most severe symptoms [33], and a German study of almost

Aetiology and pathophysiology

On the basis of the concept that central sensitisation is a common pathway of chronic sensitivity syndromes, it is presumed that sleep disturbances are due to FM-related pathophysiological changes. However, various researchers have suggested a bidirectional relationship between NRS and FM-associated pain *[46], *[47]. A number of prospective clinical studies demonstrated a correlation between FM symptoms and poor sleep quality. One statistical path analysis has shown that a night of greater

The assessment of sleep in FM patients

Despite the existence of clinical data published many years before 1990, the universally accepted diagnostic criteria of FM established by the ACR in 1990 [39] did not include disturbed sleep or NRS, or any symptoms other than pain. The newly proposed 2010 ACR Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity [38] do include patient-reported measures of unrefreshing sleep and sleep disturbances (assessed by means of visual analogue scales) to support a

Treatment options

As sleep and its integrity are clearly involved in the pathogenesis of widespread pain, it has been hypothesised that improving the various dimensions of sleep may reduce pain. This hypothesis is supported by the findings of a 15-month prospective study conducted in the UK, which showed that subjects with CWP who reported an improvement in sleep quality were more likely to experience relief from CWP [46]. It can therefore be concluded that any therapeutic approach capable of reducing or even

Summary

Recent progress in our understanding of chronic pain in FM patients has mainly been due to scientific interest moving away from attempts to identify peripheral structural muscle and tissue diseases and towards CNS mechanisms that may explain the variety of clinical features other than pain.

Sleep is an integral part of human health, and is regulated by a complex network of physiological processes. As FM patients often report sleep problems, some researchers have investigated the potential

References (138)

  • G. Affleck et al.

    Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia

    Pain

    (1996)
  • P.J. Hauri

    Insomnia

    Clinics in Chest Medicine

    (1998)
  • M.M. Ohayon et al.

    What are the contributing factors for insomnia in the general population?

    Journal of Psychosomatic Research

    (2001)
  • M.E. Geisser et al.

    A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls

    Journal of Pain

    (2008)
  • M.B. Yunus

    Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes

    Seminars in Arthritis & Rheumatism

    (2007)
  • L.M. Arnold et al.

    Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes

    American Journal of Medicine

    (2010)
  • J.A. Horne et al.

    Alpha-like EEG activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome

    Electroencephalography and Clinical Neurophysiology

    (1991)
  • J.W. Burns et al.

    Sleep stage dynamics in fibromyalgia patients and controls

    Sleep Medicine

    (2008)
  • M.G. Terzano et al.

    CAP variables and arousals as sleep electroencephalogram markers for primary insomnia

    Clinical Neurophysiology

    (2003)
  • G.K. Adler et al.

    Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

    American Journal of Medicine

    (1999)
  • R.M. Bennett et al.

    A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia

    American Journal of Medicine

    (1998)
  • H. Moldofsky

    The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome

    Rheumatic Disease Clinics of North America

    (2009)
  • I.J. Russell

    The promise of substance P inhibitors in fibromyalgia

    Rheumatic Disease Clinics of North America

    (2002)
  • M.L. Andersen et al.

    Sleep disturbance induced by substance P in mice

    Behavioural Brain Research

    (2006)
  • M.K. Erman

    Selected sleep disorders: restless legs syndrome and periodic limb movement disorder, sleep apnea syndrome, and narcolepsy

    Psychiatric Clinics of North America

    (2006)
  • P.W. Olejniczak et al.

    Sleep disorders

    Medical Clinics of North America

    (2003)
  • M.B. Yunus

    Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation

    Journal of Rheumatology

    (1992)
  • D.J. Clauw et al.

    Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

    Neuroimmunomodulation

    (1997)
  • P. Mease et al.

    Fibromyalgia syndrome

    Journal of Rheumatology

    (2007)
  • A.K. Stuifbergen et al.

    Subjective and objective sleep difficulties in women with fibromyalgia syndrome

    Journal of American Academy of Nurse Practitioners

    (2010)
  • H. Moldofsky et al.

    Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects

    Psychosomatic Medicine

    (1975)
  • C.B. Saper et al.

    Hypothalamic regulation of sleep and circadian rhythms

    Nature

    (2005)
  • K. Adam et al.

    Protein synthesis, bodily renewal and the sleep-wake cycle

    Clinical Science (London)

    (1983)
  • C.M. Shapiro et al.

    Slow-wave sleep: a recovery period after exercise

    Science

    (1981)
  • M.G. Frank

    The mystery of sleep function: current perspectives and future directions

    Reviews in the Neurosciences

    (2006)
  • L. Imeri et al.

    How (and why) the immune system makes us sleep

    Nature Reviews Neurosciences

    (2009)
  • A. Vassalli et al.

    Sleep function: current questions and new approaches

    European Journal of Neurosciences

    (2009)
  • A. Rechtschaffen et al.

    Sleep deprivation in the rat: X. Integration and discussion of the findings

    Sleep

    (1989)
  • W.M. Troxel et al.

    Sleep symptoms predict the development of the metabolic syndrome

    Sleep

    (2010)
  • M. Nishida et al.

    REM sleep, prefrontal theta, and the consolidation of human emotional memory

    Cerebral Cortex

    (2009)
  • T. Roth et al.

    Nonrestorative sleep as a distinct component of insomnia

    Sleep

    (2010)
  • D.J. Taylor et al.

    Epidemiology of insomnia, depression, and anxiety

    Sleep

    (2005)
  • P. Sarzi-Puttini et al.

    Hypersomnolence in fibromyalgia syndrome

    Clinical and Experimental Rheumatology

    (2002)
  • J.D. Edinger et al.

    Psychomotor performance deficits and their relation to prior nights’ sleep among individuals with primary insomnia

    Sleep

    (2008)
  • M.W. Johns

    A new method for measuring daytime sleepiness: the Epworth sleepiness scale

    Sleep

    (1991)
  • L.B. Krupp et al.

    The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

    Archives of Neurology

    (1989)
  • M. Martinez-Lavin et al.

    Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis

    Arthritis & Rheumatism

    (1998)
  • S. Roizenblatt et al.

    Alpha sleep characteristics in fibromyalgia

    Arthritis & Rheumatism

    (2001)
  • R.M. Bennett et al.

    An internet survey of 2,596 people with fibromyalgia

    BMC Musculoskeletal Disorders

    (2007)
  • W. Häuser et al.

    Schmerz

    (2008)
  • Cited by (0)

    View full text